Inflammation and CFTR-Related Bone Remodeling in Patients in Cystic Fibrosis

Archive ouverte

Jacquot, Jacky | Jourdain, Marie-Laure | Abdallah, Dina | Guillaume, Christine | Braux, Julien | Velard, Frédéric

Edité par CCSD ; SciMedCentral -

International audience. The hallmark pathological features of bone disease in patients with cystic fibrosis (CF) include bone micro architectural changes and chronic inflammation which are associated with an irreversible loss in bone strength and density that tracks from childhood to adulthood. Given the equal importance of inflammation and CFTR-related remodeling in bone pathogenesis, there is a significant disparity in studies undertaken to investigate the contribution of each. Up to now, the majority focus on the role of systemic and lung inflammation, and although novel therapeutics such as improved pulmonary function and inflammation have arisen, it is apparent that targeting inflammation alone has not allowed amelioration of cystic fibrosis-related bone disease (CFBD). Therefore, unless bone remodeling is addressed for future therapeutic strategies, it is unlikely that we will progress towards a cure for bone disease. Having acknowledged these limitations, the focus of this review is to highlight the gaps in our current knowledge about the mechanisms underlying CFTR-related bone remodeling, the relationships between inflammation, bone remodeling and clinical phenotypes, and the importance of utilizing innovative pre-clinical models to uncover effective, diseasemodifying therapeutic strategies.

Suggestions

Du même auteur

An Optimized Method to Generate Human Active Osteoclasts From Peripheral Blood Monocytes

Archive ouverte | Abdallah, Dina | CCSD

International audience

Osteoclastogenesis and sphingosine-1-phosphate secretion from human osteoclast precursor monocytes are modulated by the cystic fibrosis transmembrane conductance regulator

Archive ouverte | Jourdain, Marie-Laure | CCSD

International audience. Osteopenia and increased fracture rates are well-recognized in patients with cystic fibrosis (CF) disease. In CF pathology, F508del is the most common CFTR mutation, with more than 85% of pat...

Overexpression of RANKL in osteoblasts: a possible mechanism of susceptibility to bone disease in cystic fibrosis

Archive ouverte | Delion, Martial | CCSD

International audience. Bone fragility and loss are a significant cause of morbidity in patients with cystic fibrosis (CF), and the lack of effective therapeutic options means that treatment is more often palliative...

Chargement des enrichissements...